1. Home
  2. ECF vs BRTX Comparison

ECF vs BRTX Comparison

Compare ECF & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECF
  • BRTX
  • Stock Information
  • Founded
  • ECF 1986
  • BRTX 1997
  • Country
  • ECF United States
  • BRTX United States
  • Employees
  • ECF N/A
  • BRTX N/A
  • Industry
  • ECF Finance/Investors Services
  • BRTX Managed Health Care
  • Sector
  • ECF Finance
  • BRTX Health Care
  • Exchange
  • ECF Nasdaq
  • BRTX Nasdaq
  • Market Cap
  • ECF 136.0M
  • BRTX 10.7M
  • IPO Year
  • ECF N/A
  • BRTX N/A
  • Fundamental
  • Price
  • ECF $9.20
  • BRTX $1.54
  • Analyst Decision
  • ECF
  • BRTX Strong Buy
  • Analyst Count
  • ECF 0
  • BRTX 1
  • Target Price
  • ECF N/A
  • BRTX $18.00
  • AVG Volume (30 Days)
  • ECF 57.7K
  • BRTX 1.1M
  • Earning Date
  • ECF 01-01-0001
  • BRTX 03-28-2025
  • Dividend Yield
  • ECF 6.42%
  • BRTX N/A
  • EPS Growth
  • ECF N/A
  • BRTX N/A
  • EPS
  • ECF 0.46
  • BRTX N/A
  • Revenue
  • ECF N/A
  • BRTX $377,000.00
  • Revenue This Year
  • ECF N/A
  • BRTX $482.76
  • Revenue Next Year
  • ECF N/A
  • BRTX $212.24
  • P/E Ratio
  • ECF $17.61
  • BRTX N/A
  • Revenue Growth
  • ECF N/A
  • BRTX 189.55
  • 52 Week Low
  • ECF $7.02
  • BRTX $1.03
  • 52 Week High
  • ECF $8.91
  • BRTX $2.55
  • Technical
  • Relative Strength Index (RSI)
  • ECF 24.10
  • BRTX 39.03
  • Support Level
  • ECF $9.42
  • BRTX $1.46
  • Resistance Level
  • ECF $9.66
  • BRTX $1.64
  • Average True Range (ATR)
  • ECF 0.16
  • BRTX 0.26
  • MACD
  • ECF -0.07
  • BRTX -0.04
  • Stochastic Oscillator
  • ECF 0.00
  • BRTX 18.45

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: